IPOX Indexes focused on Developed Markets record strong week. IPOX China (CNI) falls. Most IPOX Indexes rose for a 2nd week, driven by firmer Europe and the perceived positive outcome of the U.S. Mid-term election. Similar to last week and ahead of U.S. option expiration week, sentiment soured towards the week-end as traders took profits amid FED-driven stubbornly stable U.S. yields. While the IPOX China (CNI) reversed last week’s strength, upside focus within the IPOX Universe was on Developed Markets exposure, with the IPOX Asia-Pacific (IPTA), IPOX Europe (IXTE) and IPOX 100 U.S. (IPXO) all recording solid gains in line or exceeding the performance of the respective benchmarks, with the IPOX 100 U.S. (IPXO) closing significantly above the key 3000 level anew. Amid earnings and significant swings in volatility, the dispersion of returns amongst the individual IPOX portfolio holdings remained big, propelling the IPOX Market Neutral Strategies to close the week at fresh YTD highs. In the U.S., e.g., strong gains in fitness club operator Planet Fitness (PLNT US: +13.87%) or cable services provider Altice USA (ATUS US: +12.83%) and a very strong week for large pharma were partially offset by the big drop in IT services provider Conduent (CNDT US: -31.55%) or social networker Match (MTCH US: -18.10%). We also note big relative gains in the IPOX Asia-Pacific (IPTA) benefiting from the surge in select Japan-traded small- and mid-caps, including pharma products maker Sanbio (4592 JP: +56.90%), nursing care services provider Solasto (6197 JP: +16.64%) or revolving sushi restaurant chain operator Sushiro Global (3563 JP: +7.43%).
IPOX® 100 U.S. Investing with the ‘FPX’ ETF since 2006
Select IPOX-linked investment products performance: Last week, the USD billion 1.1 IPOX 100 U.S. (IPXO)-linked First Trust U.S. Equity Opportunities ETF (FPX) added +1.49% to +1.39% YTD, while its international version (FPXI) rose +0.35% to close -8.69% YTD. The actively managed Catalyst IPOX® Allocation Fund (OIPAX) added +1.11% to close +5.07% YTD higher.
|Select IPOX® Indexes Returns (%)||Last Week||2017||2018 YTD|
|IPOX® Long-Only: Global/International|
|IPOX® Global (IPGL50) (USD)||-0.54||28.59||-5.05|
|IPOX® International (IPXI)* (USD)||-0.57||37.80||-10.14|
|IPOX® Long-Only: United States|
|IPOX® Composite U.S. (IPXC)*||+1.05||33.64||+0.98|
|IPOX® 100 U.S. (IPXO)*||+1.39||26.04||+0.96|
|IPOX® 30 U.S. (IPXT)||+2.11||26.63||-1.28|
|IPOX® Long-Only: Europe/Nordic|
|IPOX® 30 Europe (IXTE) (EUR)||+0.91||19.27||-4.49|
|IPOX® Nordic (IPND) (EUR)||-1.38||17.91||-7.65|
|IPOX® 100 Europe (IPOE)* (USD)||+0.01||41.77||-9.09|
|IPOX® Long-Only: Asia-Pacific/China|
|IPOX® Asia-Pacific (IPTA) (USD)||+1.60||23.30||-2.23|
|IPOX® China (CNI) (USD)||-4.31||37.67||-17.92|
|IPOX® Japan (IPJP) (JPY)||+3.09||N/A||N/A|
|IPOX® Market Neutral|
|Beta Neutral Strategy:||Yes||No|
|IPOX® Market Neutral Asia-Pacific**||X||+10.96|
|IPOX® Market Neutral Europe**||X||+17.85|
|IPOX® Market Neutral U.S.**||X||+9.19|
|IPOX® Market Neutral Global**||X||+11.05|
* Basis for ETPs: FPX US, FPX LN, FPXU FP, FPXI US, TCIP110 IT and CME-traded e-mini IPOX® 100 U.S. Futures [Symbol: IPOZ8]. ** Live since 03/18.
IPO Deal-flow Review & Outlook: U.S. IPO market sees pickup in activity with Utah-based tech unicorn Qualtrics International (XM US) gearing up for launch. 7 small caps debuted last week across accessible global regions, with the average (median) equally-weighted company adding +4.73% (+9.00%) based on the difference between the final offering price and Friday’s close. Biggest winner of the week was Chinese property management firms Xinchengyue (1755 HK: +14.14%). Priced at the low-end, the undersubscribed deal rose based on final offer. We note Sunday’s announcement of the buy-out of Utah-based SaaS company Qualtrics International (XM US), a key rival of recent IPO survey software firm SurveyMonkey (SVMK US: -10.25% YTD based on final offer and -36.65% YTD based on fist close) ahead of its listings debut. The firm was purchased for $8.0 billion by Germany’s SAP AG (SAP GY: +0.48%). The Sequoia-backed firm aimed for a $5.0 billion valuation at its IPO, double from its ca. $2.5 billion valuation a year ago. Still lined up is Nova Ljubljanska Banka (NLBR SV), the largest bank in Slovenia. This IPO is commitment made in exchange for the European’s Commission’s approval of state aid to the bank back in 2013.
|Select IPOs traded (week: 11/05/2018)||Domicile|
|CNFinance Holdings Ltd||China|
|Garofalo Health Care SpA||Italy|
|Northeast Rubber PLC||Thailand|
|Xinchenyue Holdings Ltd||China|
|Select IPOs expected (week: 11/12/2018)||Domicile|
|Centrexion Therapeutics Corp||United States|
|Ever Reach Group Holding Co Ltd||China|
|Nova Ljubljanska Banka||Slovenia|
Lime Brokerage LLC is not affiliated with these service providers. Data, information, and material (“content”) is provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lime Brokerage LLC does not endorse, offer or recommend any of the services nor information provided by any of the above service providers and any service or information used to execute any trading strategies are solely based on the independent analysis of the user.